Mycophenolate Mofetil Capsules

Type of Posting: 
Revision Bulletin
Official Date: 
01–Aug–2012
Expert Committee: 
Monographs—Small Molecules 3
Reason for Revision: 
Compliance

In accordance with the Rules and Procedures of the 2010–2015 Council of Experts, the Monographs—Small Molecules 3 Expert Committee has revised the Mycophenolate Mofetil Capsules monograph. The purpose for the revision is to add Dissolution Test 2 for a generic product approved by the FDA.

The Mycophenolate Mofetil Capsules Revision Bulletin supersedes the currently official Mycophenolate Mofetil Capsules monograph. The Revision Bulletin will be incorporated in First Supplement to USP 36–NF 31.

Should you have any questions, please contact Feiwen Mao (301-816-8320 or fm@usp.org).